Consolidated Statements Changes in Stockholders' Equity - USD ($)	Total	Convertible Notes Payable	Conversion of series D preferred stock to Class A	Conversion of series C preferred stock to Class A	Additional Paid-in Capital	Additional Paid-in Capital Convertible Notes Payable	Accumulated Deficit	Series B Preferred Stock Preferred Stock	Series C Preferred Stock Preferred Stock	Series C Preferred Stock Preferred Stock Conversion of series C preferred stock to Class A	Series D Preferred Stock Preferred Stock	Series D Preferred Stock Preferred Stock Conversion of series D preferred stock to Class A	Class A Common Stock Common Stock	Class A Common Stock Common Stock Convertible Notes Payable	Class A Common Stock Common Stock Conversion of series D preferred stock to Class A	Class A Common Stock Common Stock Conversion of series C preferred stock to Class A	Class B Common Stock Common Stock	Class C Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020								5	1,714,286		0		126,363,158				9,023,088	14,162,267
Beginning balance at Dec. 31, 2020	$ (8,788,292)				$ 30,991,978		$ (39,795,401)	$ 5	$ 171		$ 0		$ 12,636				$ 902	$ 1,417
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares of common stock for cash, net of offering costs (in shares)														9,857,397
Issuance of shares of common stock for cash, net of offering costs		$ 54,302,982				$ 54,301,997								$ 985
Issuance of shares of common stock for debt settlement (in shares)													702,877
Issuance of shares of common stock for convertible note payable and accrued interest	109,830				109,760								$ 70
Issuance of shares of series D preferred stock for acquisition (in shares)											1,428,570
Issuance of shares of series D preferred stock for acquisition	6,653,309				6,653,166						$ 143
Repurchase of class C common stock (in shares)																		(45,000)
Repurchase of class C common stock	(185,850)				(185,845)													$ (5)
Share-based compensation expense	19,341				19,341
Beneficial conversion feature on convertible notes	92,428				92,428
Net loss	(6,129,468)						(6,129,468)
Ending balance (in shares) at Mar. 31, 2021								5	1,714,286		1,428,570		136,923,432				9,023,088	14,117,267
Ending balance at Mar. 31, 2021	46,074,280				91,982,825		(45,924,869)	$ 5	$ 171		$ 143		$ 13,691				$ 902	$ 1,412
Beginning balance (in shares) at Dec. 31, 2021								5	10,149		78,674		161,798,817				8,548,088	12,500,200
Beginning balance at Dec. 31, 2021	72,111,466				131,293,861		(59,200,693)	$ 5	$ 0		$ 7		$ 16,182				$ 854	$ 1,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares of common stock for compensation (in shares)													39,386
Issuance of shares of common stock for compensation	99,252				99,248								$ 4
Conversion of convertible securities (in shares)										(10,149)		(78,674)			63,907	8,245
Conversion of convertible securities			$ 0	$ 0								$ (7)			$ 7
Share-based compensation expense	1,026				1,026
Net loss	(4,175,953)						(4,175,953)
Ending balance (in shares) at Mar. 31, 2022								5	0		0		161,910,355				8,548,088	12,500,200
Ending balance at Mar. 31, 2022	$ 68,035,791				$ 131,394,135		$ (63,376,646)	$ 5	$ 0		$ 0		$ 16,193				$ 854	$ 1,250